Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to market Pemetrexed for Injection, in the strengths of 100 mg/vial,500 mg/vial, and 1000 mg/vial Single-Dose Vials (USRLD: Alimta). Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma.
- Read more about Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
- Log in or register to post comments
source https://www.pharmatutor.org/content/may-2022/zydus-lifesciences-receives-final-approval-from-usfda-for-pemetrexed-for-injection
No comments:
Post a Comment